c-Abl Deficiency Provides Synaptic Resiliency Against Aβ-Oligomers

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Spine pathology is linked to early Alzheimer's disease (AD) onset.
• Amyloid-beta oligomers (AβOs) induce synaptic dysfunction and loss in AD.
• Pharmacological inhibition of c-Abl kinase has previously shown to prevent AβO-induced synaptic alterations.

Purpose of the Study:

• To investigate the role of c-Abl in dendritic spine morphological changes induced by AβOs.
• To utilize c-Abl null neurons (c-Abl-KO) to understand c-Abl's specific contribution to AβO pathology.

Main Methods:

• Characterization of dendritic spine density in wild-type (WT) and c-Abl-KO neurons.
• Treatment with AβOs to observe effects on spine morphology and density.
• Evaluation of synaptic contacts (PSD95/Piccolo clustering) and cell viability.

Main Results:

• Absence of c-Abl increases basal dendritic spine density.
• AβOs reduced spine number in both WT and c-Abl-KO neurons, but c-Abl deficiency did not affect this loss.
• AβOs decreased mushroom spines in c-Abl-KO neurons while preserving immature spine populations.
• Synaptic contacts and cell viability were maintained in AβOs-exposed c-Abl-KO neurons.

Conclusions:

• c-Abl kinase contributes to synaptic contact removal and increases susceptibility to AβO damage in AD.
• c-Abl deficiency enhances immature spine populations, mitigating AβO-induced synapse elimination.
• c-Abl signaling is a potential therapeutic target for early-stage Alzheimer's disease.